Time for evidence-based screening?

National Screening Committee. Annual Report. Milton Keynes: National Screening Committee, 1998.

Klein R. The New Politics of the NHS, 3rd edn. Harlow: Longman, 1995.

Stewart-Brown S. , Farmer A. Screening could seriously damage your health. BMJ 1997; 314: 533.

Elmore J.G. , Barton M.B. , Moceri V.M. Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med 1998; 338: 1089–96.

Sackett D. , Holland W.W. Controversy in the detection of disease. Lancet 1975; ii: 357.

Beardow R. , Oerton J. , Victor C. Evaluation of the cervical screening programme in an inner city health district. BMJ 1989; 299: 98–100.

Shapiro S. Evidence on screening for breast cancer from a randomized trial. Cancer 1977; 39: 2772–9.

Advisory Council on Science and Technology. A Report on Medical Research and Health. London: HMSO, 1993.

Wolf A.M. , Nasser J.F. , Schorling J.B. The impact of informed consent on patient interest in prostate-specific antigen screening. Arch Intern Med 1996; 156: 1333–6.

Wilson J.M. , Jungner G. The Principles and Practice of Screening for Disease (Public Health Papers 34). Geneva: WHO, 1968.

Morrison A.S. The effects of early treatment, lead time and length bias on the mortality experienced by cases detected by screening. Int J Epidemiol 1982; 11: 261–7.